Carlo Zivelonghi

ORCID: 0000-0001-9825-6589
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Coronary Interventions and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Cardiac Valve Diseases and Treatments
  • Acute Myocardial Infarction Research
  • Vascular Procedures and Complications
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Peripheral Artery Disease Management
  • Pain Management and Treatment
  • Cerebrovascular and Carotid Artery Diseases
  • Infective Endocarditis Diagnosis and Management
  • Cardiac Structural Anomalies and Repair
  • Mechanical Circulatory Support Devices
  • Cardiovascular Function and Risk Factors
  • Central Venous Catheters and Hemodialysis
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac and Coronary Surgery Techniques
  • Cardiac Arrhythmias and Treatments
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Disease and Adiposity
  • Aortic aneurysm repair treatments
  • Atrial Fibrillation Management and Outcomes
  • Heart Failure Treatment and Management
  • Advanced X-ray and CT Imaging
  • Coronary Artery Anomalies
  • Transplantation: Methods and Outcomes

Ziekenhuisnetwerk Antwerpen Stuivenberg
2019-2025

ZNA Middelheim Hospital
2019-2024

Hartcentrum Hasselt
2021-2024

St. Antonius Ziekenhuis
2017-2021

Abbott (Sweden)
2020

Boston Scientific (Netherlands)
2020

Abbott Vascular (United States)
2020

University of Verona
2011-2019

Institut Arnault Tzanck
2017

Ziekenhuis Oost-Limburg
2017

Acute coronary syndromes (ACS) continue to pose significant challenges for clinical practitioners, particularly regarding the prediction of mid- long-term outcomes. This study aims investigate impact in-hospital bleeding (IHB) at one-year follow-up in patients admitted ACS. Data from 23,270 enrolled international PRAISE registry and discharged after ACS were analyzed. A total 1,060 experienced IHB, while 18,765 did not; 3,445 excluded due missing data. The primary endpoint was all-cause...

10.1097/fjc.0000000000001678 article EN Journal of Cardiovascular Pharmacology 2025-02-10

Background— Aortic valve stenosis may influence fractional flow reserve (FFR) of concomitant coronary artery disease by causing hypertrophy and reducing the vasodilatory circulation. We sought to investigate whether FFR values might change after replacement. Methods Results— The functional relevance 133 lesions was assessed in 54 patients with severe aortic before transcatheter implantation (TAVI) during same procedure. A linear mixed model used verify interaction TAVI effect values. No...

10.1161/circinterventions.116.004088 article EN Circulation Cardiovascular Interventions 2016-11-01

The aim of this study was to describe the epidemiology, mechanisms, management, and outcomes coronary artery perforation during chronic total occlusion (CTO) percutaneous intervention (PCI).We included 1,811 consecutive patients undergoing CTO PCI at five centres between 2011 2018. Coronary observed in n=99 (5.5%). Patients with were older, had a higher J-CTO score, more often required antegrade dissection/re-entry retrograde approach, lower success rates. frequency Ellis type I, II, III...

10.4244/eij-d-19-00282 article EN EuroIntervention 2019-10-01

Aims:We sought to assess eventual changes in iFR measurements patients with aortic stenosis (AS) before and after TAVI coronary lesions different degrees of angiographic severity. Methods results:The functional relevance 145 was assessed by online FFR measurement 66 severe AS TAVI, during the same procedure.The iFR-FFR classification agreement calculated for pre-TAVI post-TAVI measurements.Mean values remained identical irrespective severity (0.89±0.12 vs. 0.89±0.12,p=0.66).However,...

10.4244/eij-d-17-00542 article EN EuroIntervention 2018-01-01

Background— Small observational studies demonstrate the feasibility of transradial approach for chronic total occlusion (CTO) percutaneous coronary intervention. The aim current study is to assess technical success, complication rates, and procedural efficiency in fully (fTRA) transfemoral (TFA) a large prospective European registry adopting hybrid algorithm CTO intervention (Registry CrossBoss Hybrid Procedures France, Netherlands, Belgium United Kingdom, RECHARGE registry). Methods...

10.1161/circinterventions.117.005255 article EN Circulation Cardiovascular Interventions 2017-08-30

Heavily calcified coronary artery disease presents significant challenges in percutaneous intervention (PCI), often requiring advanced techniques to achieve optimal outcomes. Cutting balloons (CB) have shown potential for plaque modification; however, their effectiveness is limited without standardized protocols.

10.1002/ccd.31387 article EN cc-by-nc-nd Catheterization and Cardiovascular Interventions 2025-01-05

Objective The use of transcatheter aortic valve implantation (TAVI) is growing rapidly in countries with a predominantly elderly population, posing huge challenge to healthcare systems worldwide. increment human and economic resource consumption imposes careful monitoring clinical outcomes cost-benefit balance, this article aimed at analysing related the TAVI learning curve. Methods Outcomes 177 consecutive transfemoral procedures performed 5 years by single team were analysed Cumulative Sum...

10.1136/openhrt-2016-000420 article EN cc-by-nc Open Heart 2016-08-01

Refractory angina is still a major public health problem. The coronary sinus Reducer (CSR) has recently been introduced as an alternative treatment to reduce symptoms in these patients. aim of this study was investigate objective improvements effort tolerance and oxygen kinetics assessed by cardiopulmonary exercise testing (CPET) patients suffering from refractory undergoing CSR implantation.In multicentre prospective study, with chronic implantation were scheduled for CPET before the index...

10.4244/eij-d-19-00766 article EN EuroIntervention 2021-04-01

The coronary sinus Reducer is a percutaneous device proven to improve angina symptoms in refractory (RA). We evaluated its potential cost-effectiveness and impact on the healthcare resource use. Angina-related usage quality-of-life data were collected for 215 consecutive RA patients undergoing implantation Belgium, Netherlands, Italy. Costs assessed from each country's system perspective. Data date of diagnosis [Standard-of-Care (SoC)-period] follow-up (Reducer-period) compared: during...

10.1093/ehjqcco/qcz027 article EN European Heart Journal - Quality of Care and Clinical Outcomes 2019-05-17

Abstract Background Refractory angina is a growing and major health-care problem affecting millions of patients with coronary artery disease worldwide. The Coronary Sinus Reducer (CSR) device that may be considered for the relief symptoms refractory angina. It causes increased venous pressure leading to dilatation arterioles reduced arterial vascular resistance in sub-endocardium. This study describes 5‑year Dutch experience regarding safety efficacy CSR. Methods One hundred thirty-two were...

10.1007/s12471-020-01525-8 article EN Netherlands Heart Journal 2020-12-07

AimsTo analyse the clinical outcome at 4 years in patients with coronary artery disease treated bare metal stents (BMS) vs. BMS and oral prednisone, or drug-eluting (DES), all assuming similar adjunctive medical treatment.

10.1093/eurheartj/eht079 article EN European Heart Journal 2013-03-14

Abstract Aim Chronic total occlusions (CTO) in patients with history of coronary artery bypass graft (CABG) show more advanced and complex atherosclerotic pathology. our study is to compare outcomes undergoing CTO percutaneous intervention (PCI) previous CABG versus those without the REgistry Crossboss Hybrid procedures FrAnce NetheRlands, BelGium UnitEd Kingdom (RECHARGE). Methods & results The RECHARGE cohort (1,252 patients) was divided two groups according presence (217) or not. We...

10.1002/ccd.28954 article EN Catheterization and Cardiovascular Interventions 2020-05-05

Abstract Background Coronary sinus (CS) narrowing by reducer implantation has emerged as a safe and effective therapy for patients suffering from refractory angina. However, data regarding the clinical benefit of this treatment over time is lacking. Methods Patients undergoing successful were enrolled prospectively to registries at three medical centers. Those with more than 2‐years follow‐up included in present analysis. Peri‐procedural data, adverse events, current evaluation angina...

10.1002/clc.23566 article EN Clinical Cardiology 2021-02-19

To assess whether combining venoarterial extracorporeal membrane oxygenation (VA-ECMO) with intra-aortic balloon pump (IABP) improves outcomes in ST-segment elevation myocardial infarction (STEMI) over VA-ECMO alone.

10.25270/jic/20.00085 article EN Deleted Journal 2021-04-20
Coming Soon ...